These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 12062599)
1. The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer. Ritter MA; Gilchrist KW; Voytovich M; Chappell RJ; Verhoven BM Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):574-80. PubMed ID: 12062599 [TBL] [Abstract][Full Text] [Related]
2. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control. Kaminski JM; Hanlon AL; Horwitz EM; Pinover WH; Mitra RK; Hanks GE Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):888-92. PubMed ID: 11958880 [TBL] [Abstract][Full Text] [Related]
3. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788 [TBL] [Abstract][Full Text] [Related]
4. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Beard CJ; Chen MH; Cote K; Loffredo M; Renshaw AA; Hurwitz M; D'Amico AV Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):19-24. PubMed ID: 14697416 [TBL] [Abstract][Full Text] [Related]
5. Dose response in prostate cancer with 8-12 years' follow-up. Hanks GE; Hanlon AL; Epstein B; Horwitz EM Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):427-35. PubMed ID: 12243818 [TBL] [Abstract][Full Text] [Related]
6. Early stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group. Lattanzi JP; Hanlon AL; Hanks GE Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):569-73. PubMed ID: 9231681 [TBL] [Abstract][Full Text] [Related]
7. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Zelefsky MJ; Hollister T; Raben A; Matthews S; Wallner KE Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1261-6. PubMed ID: 10889379 [TBL] [Abstract][Full Text] [Related]
8. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. Anderson PR; Hanlon AL; Patchefsky A; Al-Saleem T; Hanks GE Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1087-92. PubMed ID: 9719119 [TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy. Lankford SP; Pollack A; Zagars GK Int J Radiat Oncol Biol Phys; 1997 May; 38(2):327-33. PubMed ID: 9226319 [TBL] [Abstract][Full Text] [Related]
10. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era. Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452 [TBL] [Abstract][Full Text] [Related]
11. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961 [TBL] [Abstract][Full Text] [Related]
12. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
14. Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer. Pinover WH; Hanlon AL; Horwitz EM; Hanks GE Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):649-54. PubMed ID: 10837947 [TBL] [Abstract][Full Text] [Related]
15. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Kupelian PA; Buchsbaum JC; Patel C; Elshaikh M; Reddy CA; Zippe C; Klein EA Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):704-11. PubMed ID: 11849793 [TBL] [Abstract][Full Text] [Related]
16. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237 [TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. Shipley WU; Thames HD; Sandler HM; Hanks GE; Zietman AL; Perez CA; Kuban DA; Hancock SL; Smith CD JAMA; 1999 May; 281(17):1598-604. PubMed ID: 10235152 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy. Lee AK; Levy LB; Cheung R; Kuban D Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):456-62. PubMed ID: 15927415 [TBL] [Abstract][Full Text] [Related]
19. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen. Zagars GK; Pollack A; von Eschenbach AC Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892 [TBL] [Abstract][Full Text] [Related]
20. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality. Kollmeier MA; Stock RG; Stone N Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):645-53. PubMed ID: 14529768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]